Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial (vol 42, pg 9, 2006)

被引：0
|
作者：
Aoki, FY
Tyring, S
Diaz-Mitoma, F
Gross, G
Gao, J
Hamed, K
机构：
来源：
CLINICAL INFECTIOUS DISEASES | 2006年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：588 / 588
页数：1
相关论文
共 50 条
  • [1] Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: A randomized, double-blind, placebo-controlled trial
    Aoki, FY
    Tyring, S
    Diaz-Mitoma, F
    Gross, G
    Gao, J
    Hamed, K
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (01) : 8 - 13
  • [2] Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: A randomized, double-blind, comparative trial
    Abudalu, Mohammed
    Tyring, Stephen
    Koltun, William
    Bodsworth, Neil
    Hamed, Kamal
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 (05) : 651 - 658
  • [3] A double-blind, randomized, placebo-controlled trial of 1-day, patient-initiated famciclovir 1000 mg bid for the treatment of recurrent genital herpes
    Tyring, S
    Diaz-Mitoma, F
    Aoki, F
    Hamed, K
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB155 - AB155
  • [4] Single-dose, patient-initiated famciclovir: A randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis
    Spruance, Spotswood L.
    Bodsworth, Neil
    Resnick, Harvey
    Conant, Marcus
    Oeuvray, Claude
    Gao, Joseph
    Hamed, Kamal
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (01) : 47 - 53
  • [5] Single-Dose, Patient-Initiated Amenamevir Therapy for Recurrent Genital Herpes: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Kawashima, Makoto
    Imafuku, Shinichi
    Fujio, Kosuke
    Komazaki, Hiroshi
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (10):
  • [6] Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes - A randomized, double-blind multicenter trial
    Sacks, SL
    Aoki, FY
    DiazMitoma, F
    Sellors, J
    Shafran, SD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (01): : 44 - 49
  • [7] A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis
    Kawashima, Makoto
    Watanabe, Daisuke
    Fujio, Kosuke
    Komazaki, Hiroshi
    [J]. JOURNAL OF DERMATOLOGY, 2023, 50 (03): : 311 - 318
  • [8] Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women - A multicenter, double-blind, placebo-controlled trial
    Mertz, GJ
    Loveless, MO
    Levin, MJ
    Kraus, SJ
    Fowler, SL
    Goade, D
    Tyring, SK
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (03) : 343 - 349
  • [9] Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: A randomized, double-blind, controlled trial
    Sacks, SL
    Aoki, FY
    Martel, AY
    Shafran, SD
    Lassonde, M
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (08) : 1097 - 1104
  • [10] Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: A patient-initiated, double-blind, placebo-controlled trial
    Hull, Christopher
    McKeough, Mark
    Sebastian, Katherine
    Spruance, Spotswood
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB92 - AB92
12345